Adipokines: a link between obesity and dementia?

Gustafson, 2003, An 18-year follow-up of overweight and risk of Alzheimer disease, Arch Intern Med, 163, 1524, 10.1001/archinte.163.13.1524 Whitmer, 2007, Body mass index in midlife and risk of Alzheimer disease and vascular dementia, Curr Alzheimer Res, 4, 103, 10.2174/156720507780362047 Whitmer, 2008, Central obesity and increased risk of dementia more than three decades later, Neurology, 71, 1057, 10.1212/01.wnl.0000306313.89165.ef Fitzpatrick, 2009, Midlife and late-life obesity and the risk of dementia: cardiovascular health study, Arch Neurol, 66, 336, 10.1001/archneurol.2008.582 Kivipelto, 2005, Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease, Arch Neurol, 62, 1556, 10.1001/archneur.62.10.1556 Gustafson, 2009, Adiposity indicators and dementia over 32 years in Sweden, Neurology, 73, 1559, 10.1212/WNL.0b013e3181c0d4b6 Hayden, 2006, Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study, Alzheimer Dis Assoc Disord, 20, 93, 10.1097/01.wad.0000213814.43047.86 Besser, 2014, Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer's disease, Alzheimer Dis Assoc Disord, 28, 36, 10.1097/WAD.0000000000000005 Gustafson, 2012, Adiposity and cognitive decline: underlying mechanisms, J Alzheimers Dis, 30, S97, 10.3233/JAD-2012-120487 Arnoldussen, 2014, Obesity and dementia: adipokines interact with the brain, Eur J Neuropsychopharmacol, 10.1016/j.euroneuro.2014.03.002 Chen, 2009, Risk factors for dementia, J Formos Med Assoc, 108, 754, 10.1016/S0929-6646(09)60402-2 Prunet-Marcassus, 2006, From heterogeneity to plasticity in adipose tissues: site-specific differences, Exp Cell Res, 312, 727, 10.1016/j.yexcr.2005.11.021 Vindigni, 2013, Preliminary report of in vitro reconstruction of a vascularized tendon-like structure: a novel application for adipose-derived stem cells, Ann Plastic Surg, 71, 664, 10.1097/SAP.0b013e3182583e99 2010 Lehr, 2012, Identification and validation of novel adipokines released from primary human adipocytes, Mol Cell Proteomics, 11, 10.1074/mcp.M111.010504 Avram, 2005, Subcutaneous fat in normal and diseased states: 2. Anatomy and physiology of white and brown adipose tissue, J Am Acad Dermatol, 53, 671, 10.1016/j.jaad.2005.05.015 Sbarbati, 2010, Subcutaneous adipose tissue classification, Eur J Histochem, 54, e48, 10.4081/ejh.2010.e48 Villarroya, 2013, An endocrine role for brown adipose tissue?, Am J Physiol Endocrinol Metab, 305, E567, 10.1152/ajpendo.00250.2013 Esteve Rafols, 2014, Adipose tissue: cell heterogeneity and functional diversity, Endocrinol Nutr, 61, 100, 10.1016/j.endonu.2013.03.011 Feng, 2013, Human adipose dynamics and metabolic health, Ann N Y Acad Sci, 1281, 160, 10.1111/nyas.12009 Ferland, 1989, Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements, Br J Nutr, 61, 139, 10.1079/BJN19890104 Pouliot, 1994, Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women, Am J Cardiol, 73, 460, 10.1016/0002-9149(94)90676-9 Seidell, 1988, Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age, Eur J Clin Nutr, 42, 805 Gallagher, 1996, How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?, Am J Epidemiol, 143, 228, 10.1093/oxfordjournals.aje.a008733 Campbell, 1993, Flavonoid inhibition of aromatase enzyme activity in human preadipocytes, J Steroid Biochem Mol Biol, 46, 381, 10.1016/0960-0760(93)90228-O Gustafson, 2010, Adiposity hormones and dementia, J Neurol Sci, 299, 30, 10.1016/j.jns.2010.08.036 2006 1999 Erta, 2012, Interleukin-6, a major cytokine in the central nervous system, Int J Biol Sci, 8, 1254, 10.7150/ijbs.4679 Wenk, 2003, Neuropathologic changes in Alzheimer's disease, J Clin Psychiatry, 64, 7 Michaud, 2013, Proinflammatory cytokines, aging, and age-related diseases, J Am Med Dir Assoc, 14, 877, 10.1016/j.jamda.2013.05.009 Van de Voorde, 2013, Adipocytokines in relation to cardiovascular disease, Metabolism, 62, 1513, 10.1016/j.metabol.2013.06.004 Bays, 2011, Adiposopathy is “sick fat” a cardiovascular disease?, J Am Coll Cardiol, 57, 2461, 10.1016/j.jacc.2011.02.038 Catindig, 2012, Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors, J Neurol Sci, 321, 11, 10.1016/j.jns.2012.07.023 Balistreri, 2010, The role of adipose tissue and adipokines in obesity related inflammatory diseases, Mediators Inflamm, 2010, 802078, 10.1155/2010/802078 Duvnjak, 2009, The metabolic syndrome—an ongoing story, J Physiol Pharmacol, 60, 19 Figlewicz, 2003, Adiposity signals and food reward: expanding the CNS roles of insulin and leptin, Am J Physiol Regul Integr Comp Physiol, 284, R882, 10.1152/ajpregu.00602.2002 Hill, 2010, Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility, Cell Metab, 11, 286, 10.1016/j.cmet.2010.03.002 Gustafson, 2012, Leptin and dementia over 32 years—The Prospective Population Study of Women, Alzheimers Dement, 8, 272, 10.1016/j.jalz.2011.05.2411 Lieb, 2009, Association of plasma leptin levels with incident Alzheimer's disease and MRI measures of brain aging, JAMA, 302, 2565, 10.1001/jama.2009.1836 Zeki Al Hazzouri, 2013, Leptin, mild cognitive impairment, and dementia among elderly women, J Gerontol A Biol Sci Med Sci, 68, 175, 10.1093/gerona/gls155 Holden, 2009, Serum leptin level and cognition in the elderly: findings from the Health ABC Study, Neurobiol Aging, 30, 1483, 10.1016/j.neurobiolaging.2007.11.024 Ban, 2007, Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia, Atherosclerosis, 195, 153, 10.1016/j.atherosclerosis.2006.09.005 van Himbergen, 2012, Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study, Arch Neurol, 69, 594, 10.1001/archneurol.2011.670 Roberts, 2009, Association of C-reactive protein with mild cognitive impairment, Alzheimers Dement, 5, 398, 10.1016/j.jalz.2009.01.025 Une, 2011, Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease, Eur J Neurol, 18, 1006, 10.1111/j.1468-1331.2010.03194.x Teixeira, 2013, Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease, Neuromolecular Med, 15, 115, 10.1007/s12017-012-8201-2 Tan, 2007, Inflammatory markers and the risk of Alzheimer disease: the Framingham Study, Neurology, 68, 1902, 10.1212/01.wnl.0000263217.36439.da Yaffe, 2004, The metabolic syndrome, inflammation, and risk of cognitive decline, JAMA, 292, 2237, 10.1001/jama.292.18.2237 van Exel, 2009, Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease, Arch Gen Psychiatry, 66, 1263, 10.1001/archgenpsychiatry.2009.146 Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue, Nature, 372, 425, 10.1038/372425a0 Maffei, 1995, Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects, Nat Med, 1, 1155, 10.1038/nm1195-1155 Banks, 2003, Is obesity a disease of the blood–brain barrier? Physiological, pathological, and evolutionary considerations, Curr Pharm Des, 9, 801, 10.2174/1381612033455350 Friedman, 1998, Leptin and the regulation of body weight in mammals, Nature, 22, 763, 10.1038/27376 Lissner, 1999, Birth weight, adulthood BMI, and subsequent weight gain in relation to leptin levels in Swedish women, Obes Res, 7, 150, 10.1002/j.1550-8528.1999.tb00696.x Gustafson, 2012, 37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden, J Alzheimers Dis, 28, 163, 10.3233/JAD-2011-110917 Peiser, 2000, Binding and internalization of leptin by porcine choroid plexus cells in culture, Neurosci Lett, 283, 209, 10.1016/S0304-3940(00)00942-3 Zlokovic, 2000, Differential regulation of leptin transport by the choroid plexus and blood–brain barrier and high affinity transport systems for entry into hypothalamus and across the blood–cerebrospinal fluid barrier, Endocrinology, 141, 1434, 10.1210/endo.141.4.7435 Wiesner, 1999, Leptin is released from the human brain: influence of adiposity and gender, J Clin Endocrinol Metab, 84, 2270 Morash, 1999, Leptin gene expression in the brain and pituitary gland, Endocrinology, 140, 5995, 10.1210/endo.140.12.7288 Brown, 2007, Adipokine gene expression in a novel hypothalamic neuronal cell line: resistin-dependent regulation of fasting-induced adipose factor and SOCS-3, Neuroendocrinology, 85, 232, 10.1159/000104248 Brown, 2008, Traumatic brain injury induces adipokine gene expression in rat brain, Neurosci Lett, 432, 73, 10.1016/j.neulet.2007.12.008 Wilkinson, 2007, Adipokine gene expression in brain and pituitary gland, Neuroendocrinology, 86, 191, 10.1159/000108635 Schulz, 2010, Adipocyte–brain: crosstalk, Results Probl Cell Differ, 52, 189, 10.1007/978-3-642-14426-4_16 Bluher, 2009, Adipose tissue dysfunction in obesity, Exp Clin Endocrinol Diabet, 117, 241, 10.1055/s-0029-1192044 Abizaid, 2008, Brain circuits regulating energy homeostasis, Regul Pept, 149, 3, 10.1016/j.regpep.2007.10.006 Bluher, 2009, Leptin in humans: lessons from translational research, Am J Clin Nutr, 89, 991S, 10.3945/ajcn.2008.26788E Harvey, 2005, Leptin: a potential cognitive enhancer?, Biochem Soc Trans, 33, 1029, 10.1042/BST20051029 Davidson, 2005, Memory inhibition and energy regulation, Physiol Behav, 86, 731, 10.1016/j.physbeh.2005.09.004 Oomura, 2010, Prandial increase of leptin in the brain activates spatial learning and memory, Pathophysiology, 17, 119, 10.1016/j.pathophys.2009.04.004 Fewlass, 2004, Obesity-related leptin regulates Alzheimer's Abeta, FASEB J, 18, 1870, 10.1096/fj.04-2572com Kishi, 2005, Body weight is regulated by the brain: a link between feeding and emotion, Mol Psychiatry, 10, 132, 10.1038/sj.mp.4001638 Qi, 2004, Adiponectin acts in the brain to decrease body weight, Nat Med, 10, 524, 10.1038/nm1029 Carro, 2009, Therapeutic approaches of leptin in Alzheimer's disease, Recent Pat CNS Drug Discov, 4, 200, 10.2174/157488909789104848 Sinha, 2007, Analytical validation and biological evaluation of a high molecular-weight adiponectin ELISA, Clin Chem, 53, 2144, 10.1373/clinchem.2007.090670 Chandran, 2003, Adiponectin: more than just another fat cell hormone?, Diabet Care, 26, 2442, 10.2337/diacare.26.8.2442 Kubota, 2007, Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake, Cell Metab, 6, 55, 10.1016/j.cmet.2007.06.003 Kusminski, 2007, Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum, Diabetologia, 50, 634, 10.1007/s00125-006-0577-9 Kos, 2007, Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus, J Clin Endocrinol Metab, 92, 1129, 10.1210/jc.2006-1841 Kang, 2009, Molecular cloning, gene expression, and tissue distribution of adiponectin and its receptors in the Japanese monkey, Macaca fuscata, J Med Primatol, 38, 77, 10.1111/j.1600-0684.2008.00298.x Angelidis, 2013, The emerging roles of adiponectin in female reproductive system-associated disorders and pregnancy, Reprod Sci, 20, 872, 10.1177/1933719112468954 Qiu, 2011, Adiponectin protects rat hippocampal neurons against excitotoxicity, Age (Dordr), 33, 155, 10.1007/s11357-010-9173-5 Fry, 2006, Area postrema neurons are modulated by the adipocyte hormone adiponectin, J Neurosci, 26, 9695, 10.1523/JNEUROSCI.2014-06.2006 Buchman, 2005, Change in body mass index and risk of incident Alzheimer disease, Neurology, 65, 892, 10.1212/01.wnl.0000176061.33817.90 Lenchik, 2003, Adiponectin as a novel determinant of bone mineral density and visceral fat, Bone, 33, 646, 10.1016/S8756-3282(03)00237-0 Ryan, 2003, Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity, Diabetes Care, 26, 2383, 10.2337/diacare.26.8.2383 Drolet, 2009, Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women, Obesity, 17, 424, 10.1038/oby.2008.555 Blogowski, 2013, Clinical analysis of selected complement-derived molecules in human adipose tissue, J Transl Med, 11, 11, 10.1186/1479-5876-11-11 Searfoss, 2003, Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor, J Biol Chem, 278, 46107, 10.1074/jbc.M307757200 Giordano, 2011, Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents, Eur J Pediatr, 170, 845, 10.1007/s00431-010-1356-7 Mantovani, 2011, Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity, J Pediatr Endocrinol Metab, 24, 361, 10.1515/jpem.2011.015 Singh, 2012, Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state, Br J Haematol, 158, 523, 10.1111/j.1365-2141.2012.09160.x Greenberg, 2006, Obesity and the role of adipose tissue in inflammation and metabolism, Am J Clin Nutr, 83, 461S, 10.1093/ajcn/83.2.461S Guerre-Millo, 2004, Adipose tissue and adipokines: for better or worse, Diabetes Metab, 30, 13, 10.1016/S1262-3636(07)70084-8 Loskutoff, 1989, Type 1 plasminogen activator inhibitor, Prog Hemost Thromb, 9, 87 Skurk, 2004, Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1, Int J Obes Relat Metab Disord, 28, 1357, 10.1038/sj.ijo.0802778 Ahn, 1999, Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice, Brain Res, 837, 169, 10.1016/S0006-8993(99)01645-5 Jeon, 2012, Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity, J Neuroinflammation, 9, 149, 10.1186/1742-2094-9-149 Soeda, 2008, Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system, Thrombosis Haemostasis, 100, 1014, 10.1160/TH08-04-0259 Soeda, 2001, Deficient release of plasminogen activator inhibitor-1 from astrocytes triggers apoptosis in neuronal cells, Brain Res Mol Brain Res, 91, 96, 10.1016/S0169-328X(01)00133-4 Ciccone, 2013, Endovascular treatment for acute ischemic stroke, N Engl J Med, 368, 904, 10.1056/NEJMoa1213701 Kasza, 2001, Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells, Cytokine, 16, 187, 10.1006/cyto.2001.0957 Murakami, 2013, Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats, Brain Res, 1526, 84, 10.1016/j.brainres.2013.06.014 Melchor, 2003, The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-b (Ab) degradation and inhibits Ab-induced neurodegeneration, J Neurosci, 23, 8867, 10.1523/JNEUROSCI.23-26-08867.2003 Medina, 2005, Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation, EMBO J, 24, 1706, 10.1038/sj.emboj.7600650 Barker, 2012, Activators and inhibitors of the plasminogen system in Alzheimer's disease, J Cell Mol Med, 16, 865, 10.1111/j.1582-4934.2011.01394.x Das, 2001, Is obesity an inflammatory condition?, Nutrition, 17, 953, 10.1016/S0899-9007(01)00672-4 Boulanger, 2003, Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex, Science, 300, 2101, 10.1126/science.1083901 Banks, 1994, Penetration of interleukin-6 across the murine blood-brain barrier, Neurosci Lett, 179, 53, 10.1016/0304-3940(94)90933-4 Frei, 1989, On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases, Eur J Immunol, 19, 689, 10.1002/eji.1830190418 Lieberman, 1989, Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus, Proc Natl Acad Sci USA, 86, 6348, 10.1073/pnas.86.16.6348 Fabry, 1993, Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes, J Neuroimmunol, 47, 23, 10.1016/0165-5728(93)90281-3 Balschun, 2004, Interleukin-6: a cytokine to forget, FASEB J, 18, 1788, 10.1096/fj.04-1625fje Nelson, 2012, Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6, Brain Behav Immun, 26, 959, 10.1016/j.bbi.2012.05.005 Richwine, 2008, Architectural changes to CA1 pyramidal neurons in adult and aged mice after peripheral immune stimulation, Psychoneuroendocrinology, 33, 1369, 10.1016/j.psyneuen.2008.08.003 Tancredi, 2000, The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK, J Neurochem, 75, 634, 10.1046/j.1471-4159.2000.0750634.x Ropelle, 2010, IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKβ and ER stress inhibition, PLoS Biol, 8, e1000465, 10.1371/journal.pbio.1000465 Marsland, 2008, Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults, Biol Psychiatry, 64, 484, 10.1016/j.biopsych.2008.04.016 Sartipy, 2003, Monocyte chemoattractant protein 1 in obesity and insulin resistance, Proc Natl Acad Sci USA, 100, 7265, 10.1073/pnas.1133870100 Samad, 2000, Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes, Mol Med, 6, 680, 10.1007/BF03402048 Shimomura, 2000, Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice, Mol Cell, 6, 77, 10.1016/S1097-2765(05)00010-9 Cusi, 2000, Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle, J Clin Invest, 105, 311, 10.1172/JCI7535 Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest, 104, 447, 10.1172/JCI5971 Kanda, 2006, MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, J Clin Invest, 116, 1494, 10.1172/JCI26498 Ho, 2012, Elevated plasma MCP-1 concentration following traumatic brain injury as a potential “predisposition” factor associated with an increased risk for subsequent development of Alzheimer's disease, J Alzheimers Dis, 31, 301, 10.3233/JAD-2012-120598 Jung, 2009, Hepatocyte growth factor is elevated in obese adolescents, J Pediatr Endocrinol Metab, 22, 645, 10.1515/JPEM.2009.22.7.645 Bell, 2006, Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity, Am J Physiol Endocrinol Metabol, 291, E843, 10.1152/ajpendo.00174.2006 Jung, 1994, Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain, J Cell Biol, 126, 485, 10.1083/jcb.126.2.485 Powell, 2003, Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction, J Neurosci, 23, 622, 10.1523/JNEUROSCI.23-02-00622.2003 Nagayama, 2004, Post-ischemic delayed expression of hepatocyte growth factor and c-Met in mouse brain following focal cerebral ischemia, Brain Res, 999, 155, 10.1016/j.brainres.2003.11.052 Fenton, 1998, Hepatocyte growth factor (HGF/SF) in Alzheimer's disease, Brain Res, 779, 262, 10.1016/S0006-8993(97)00958-X Akimoto, 2004, Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus, Neuroscience, 128, 155, 10.1016/j.neuroscience.2004.06.031 Date, 2004, Hepatocyte growth factor improved learning and memory dysfunction of microsphere-embolized rats, J Neurosci Res, 78, 442, 10.1002/jnr.20263 Shimamura, 2012, Development of nucleic acid drugs for neurological disorders, Curr Top Med Chem, 12, 1621, 10.2174/156802612803531405 Manni, 2013, Nerve growth factor: basic studies and possible therapeutic applications, Growth Factors, 31, 115, 10.3109/08977194.2013.804073 Cattaneo, 2012, Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis, Mol Neurobiol, 46, 588, 10.1007/s12035-012-8310-9 Fragkouli, 2011, Matrix metalloproteinase-9 participates in NGF-induced alpha-secretase cleavage of amyloid-beta protein precursor in PC12 cells, J Alzheimers Dis, 24, 705, 10.3233/JAD-2011-101893 Giacobini, 2007, One hundred years after the discovery of Alzheimer's disease. A turning point for therapy?, J Alzheimers Dis, 12, 37, 10.3233/JAD-2007-12105 Konukoglu, 2012, Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia, Acta Neurol Belg, 112, 255, 10.1007/s13760-012-0101-6 Blasko, 2006, Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias, Dement Geriatr Cogn Disord, 21, 9, 10.1159/000089137 Tian, 2012, Intranasal administration of nerve growth factor ameliorate beta-amyloid deposition after traumatic brain injury in rats, Brain Res, 1440, 47, 10.1016/j.brainres.2011.12.059 Lee, 2007, Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies, Cancer Epidemiol Biomarkers Prev, 16, 2464, 10.1158/1055-9965.EPI-07-0374 Azrad, 2013, Racial differences in adiponectin and leptin in healthy premenopausal women, Endocrine, 43, 586, 10.1007/s12020-012-9797-6 Khan, 2012, Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN), Metab Clin Exp, 61, 1261, 10.1016/j.metabol.2012.02.005 Cruz-Jentoft, 2010, Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People, Age Ageing, 39, 412, 10.1093/ageing/afq034 Stevens, 1998, The effect of age on the association between body-mass index and mortality, N Engl J Med, 338, 1, 10.1056/NEJM199801013380101